Human Gut Microbiota and Gastrointestinal Cancer.

Citation data:

Genomics, proteomics & bioinformatics, ISSN: 2210-3244, Vol: 16, Issue: 1, Page: 33-49

Publication Year:
2018
Usage 4
Abstract Views 4
Captures 54
Readers 54
Mentions 1
Blog Mentions 1
Social Media 22
Tweets 13
Shares, Likes & Comments 9
Citations 3
Citation Indexes 3
Repository URL:
https://digitalcommons.psjhealth.org/publications/13
PMID:
29474889
DOI:
10.1016/j.gpb.2017.06.002
Author(s):
Meng, Changting; Bai, Chunmei; Brown, Thomas D; Hood, Leroy E; Tian, Qiang
Publisher(s):
Elsevier BV
Tags:
Biochemistry, Genetics and Molecular Biology; Mathematics; Carcinogenesis; Immune regulation; Inflammation; Microbial metabolites; Traditional Chinese Medicine; Carcinogenesis; Immune regulation; Inflammation; Microbial metabolites; Traditional Chinese Medicine; Alternative and Complementary Medicine; Gastroenterology; Oncology
Most Recent Tweet View All Tweets
Most Recent Blog Mention
review description
Human gut microbiota play an essential role in both healthy and diseased states of humans. In the past decade, the interactions between microorganisms and tumors have attracted much attention in the efforts to understand various features of the complex microbial communities, as well as the possible mechanisms through which the microbiota are involved in cancer prevention, carcinogenesis, and anti-cancer therapy. A large number of studies have indicated that microbial dysbiosis contributes to cancer susceptibility via multiple pathways. Further studies have suggested that the microbiota and their associated metabolites are not only closely related to carcinogenesis by inducing inflammation and immune dysregulation, which lead to genetic instability, but also interfere with the pharmacodynamics of anticancer agents. In this article, we mainly reviewed the influence of gut microbiota on cancers in the gastrointestinal (GI) tract (including esophageal, gastric, colorectal, liver, and pancreatic cancers) and the regulation of microbiota by diet, prebiotics, probiotics, synbiotics, antibiotics, or the Traditional Chinese Medicine. We also proposed some new strategies in the prevention and treatment of GI cancers that could be explored in the future. We hope that this review could provide a comprehensive overview of the studies on the interactions between the gut microbiota and GI cancers, which are likely to yield translational opportunities to reduce cancer morbidity and mortality by improving prevention, diagnosis, and treatment.